Summary
- Current Price
- As of today, AMPH price is $19.23, down -1.38% on
- Current Price All-Time High
- AMPH price is currently -71.58% below its historical high of $67.66 set on
- Market Cap
- AMPH current market cap is $894M, down -34.07% year-over-year
- PE Ratio
- AMPH current PE ratio is 9.46
- Revenue
- AMPH current annual revenue is $719.89M, down -1.65% year-over-year
- Next Earnings
- The next earnings release for AMPH is on
Profile
| Metric | Value |
|---|---|
| Full Name | Amphastar Pharmaceuticals, Inc. |
| Ticker | NASDAQ: AMPH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | amphastar.com |
| Employees | 2,028 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $19.23 | |
| Price, 1D Change | -1.38% | |
| $894M | ||
| - | ||
| 9.46 | ||
| 0.93 | ||
| $720M | ||
| Revenue, 1Y Change | -1.65% | |
| $2.03 | ||
| EPS, 1Y Change | -33.61% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $2.03 | ||
| EPS Estimate | N/A | $3.31 |
| EPS Est. Change | N/A | +62.82% |
| $719.89M | ||
| Revenue Estimate | N/A | $756.49M |
| Revenue Est. Change | N/A | +5.08% |
| Current Price | $19.23 | |
| Price Target | - | $30.00 |
| Price Tgt. Change | - | +56.01% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.87 | $3.06 | -20.87% | |
| $3.37 | $2.03 | -39.71% | |
| $3.31 | N/A | +62.82% | |
| $3.49 | N/A | +71.52% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $734.35M | $731.97M | -0.32% | |
| $726.98M | $719.89M | -0.98% | |
| $756.49M | N/A | +5.08% | |
| $792.50M | N/A | +10.09% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $19.23 | |
| $25.52 | ||
| SMA 200 vs Price | +32.71% | |
| $24.81 | ||
| SMA 50 vs Price | +29.00% | |
| 0.93 | ||
| $1.07 | ||
| 33.35 | ||
| 46.05% | ||
| 49.50% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $719.89M | ||
| $2.03 | ||
| $0.00 | ||
| 47.43% | ||
| $140.40M | ||
| 19.50% | ||
| $98.09M | ||
| 13.63% | ||
| $203.60M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.83 | ||
| 4.02 | ||
| 2.90 | ||
| - | ||
| 6 | ||
| 1.93 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 9.46 | ||
| 1.24 | ||
| 1.13 | ||
| 6.21 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $788.80M | ||
| $285.25M | ||
| $1.68B | ||
| $636.02M | ||
| $888.89M | ||
| $158.16M | ||
| $656.00M | ||
| $9.57M | ||
| $32.59M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $621.79M | ||
| $201.05M | ||
| $378.43M | ||
| $129.81M | ||
| $63.20M | ||
| $0.00 | ||
| $25.53M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $156.12M | ||
| -$70.33M | ||
| -$67.43M | ||
| $37.13M | ||
| $118.98M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Needham | → | |
| Barclays | ||
| Needham | → | |
| Needham | → | |
| B of A Securities | → | |
| Needham | → | |
| Piper Sandler | → | |
| JP Morgan | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with AMPH
FAQ
What is the ticker symbol for Amphastar Pharmaceuticals, Inc.?
The ticker symbol for Amphastar Pharmaceuticals, Inc. is NASDAQ:AMPH
Does Amphastar Pharmaceuticals, Inc. pay dividends?
No, Amphastar Pharmaceuticals, Inc. does not pay dividends
What sector is Amphastar Pharmaceuticals, Inc. in?
Amphastar Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Amphastar Pharmaceuticals, Inc. in?
Amphastar Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Amphastar Pharmaceuticals, Inc. based in?
Amphastar Pharmaceuticals, Inc. is headquartered in United States
When did Amphastar Pharmaceuticals, Inc. go public?
Amphastar Pharmaceuticals, Inc. initial public offering (IPO) was on June 25, 2014
Is Amphastar Pharmaceuticals, Inc. in the S&P 500?
No, Amphastar Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Amphastar Pharmaceuticals, Inc. in the NASDAQ 100?
No, Amphastar Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Amphastar Pharmaceuticals, Inc. in the Dow Jones?
No, Amphastar Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Amphastar Pharmaceuticals, Inc. last earnings report?
Amphastar Pharmaceuticals, Inc.'s most recent earnings report was on February 26, 2026
When does Amphastar Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Amphastar Pharmaceuticals, Inc. is May 6, 2026
Data Sources & References
- AMPH Official Website www.amphastar.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1297184/000129718426000009/0001297184-26-000009-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1297184/000129718426000009/0001297184-26-000009-index.htm
- AMPH Profile on Yahoo Finance finance.yahoo.com/quote/AMPH
- AMPH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amph
